Jean-Yves Pavee, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 10,500 shares at $49.00 ($515K) on 2015-06-03, disclosed to the SEC on 2015-06-05.
Scheduled sale ($514k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ABT | SELL | 2015-03-03 | $31K | — | Filing → |
| ABT | SELL | 2015-02-18 | $29K | — | Filing → |
| ABT | SELL | 2014-02-19 | $19K | — | Filing → |